441 related articles for article (PubMed ID: 10579094)
1. Evaluation of the in vitro antimicrobial activity of cefepime compared to other broad-spectrum beta-lactams tested against recent clinical isolates from 10 Chinese hospitals. Chinese Antimicrobial Resistance Study Group.
Xu Y; Chen M; Biedenbach DJ; Deshpande LM; Jones RN
Diagn Microbiol Infect Dis; 1999 Oct; 35(2):135-42. PubMed ID: 10579094
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
[TBL] [Abstract][Full Text] [Related]
3. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Jones RN; Salazar JC; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of cefepime and other broad-spectrum beta-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study Group.
Biedenbach DJ; Lewis MT; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):277-83. PubMed ID: 10668586
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of cefepime and other broad-spectrum beta-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study Group.
Lewis MT; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):285-90. PubMed ID: 10668587
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study Group.
Johnson DM; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):291-7. PubMed ID: 10668588
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of cefepime and other broad-spectrum beta-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samples. The Japan Antimicrobial Resistance Study Group.
Lewis MT; Yamaguchi K; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):307-15. PubMed ID: 10668590
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
Jones RN; Pfaller MA; Doern GV; Erwin ME; Hollis RJ
Diagn Microbiol Infect Dis; 1998 Mar; 30(3):215-28. PubMed ID: 9572029
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of broad-spectrum beta-lactams tested in medical centers in Korea: role of fourth-generation cephalosporins. The Korean Antimicrobial Resistance Study Group.
Lewis MT; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):317-23. PubMed ID: 10668591
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of cefepime and other broad-spectrum beta-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study Group.
Biedenbach DJ; Johnson DM; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):299-305. PubMed ID: 10668589
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antimicrobial susceptibility for beta-lactams using the Etest method against clinical isolates from 100 medical centers in Japan (2006).
Ishii Y; Tateda K; Yamaguchi K;
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):177-83. PubMed ID: 17931820
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group.
Biedenbach DJ; Johnson DM; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):325-31. PubMed ID: 10668592
[TBL] [Abstract][Full Text] [Related]
13. Multicenter evaluation of the antimicrobial activity for seven broad-spectrum beta-lactams in Turkey using the Etest method. Turkish Antimicrobial Resistance Study Group.
Pfaller MA; Korten V; Jones RN; Doern GV
Diagn Microbiol Infect Dis; 1999 Sep; 35(1):65-73. PubMed ID: 10529883
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
Ishii Y; Ueda C; Kouyama Y; Tateda K; Yamaguchi K
Diagn Microbiol Infect Dis; 2011 Apr; 69(4):443-8. PubMed ID: 21396543
[TBL] [Abstract][Full Text] [Related]
15. Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group.
Pfaller MA; Jones RN; Doern GV
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):45-52. PubMed ID: 9488831
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antimicrobial activity of beta-lactam antibiotics using Etest against clinical isolates from 60 medical centres in Japan.
Ishii Y; Alba J; Kimura S; Shiroto K; Yamaguchi K
Int J Antimicrob Agents; 2005 Apr; 25(4):296-301. PubMed ID: 15784308
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antimicrobial activity of beta-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004).
Ishii Y; Alba J; Kimura S; Yamaguchi K
Diagn Microbiol Infect Dis; 2006 Jun; 55(2):143-8. PubMed ID: 16529905
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method].
Xu Y; Chen M; Zhang S
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):362-5. PubMed ID: 11798789
[TBL] [Abstract][Full Text] [Related]
20. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
